沃拉西迪尼布治疗IDH突变2级质瘤:临床进展和未来方向
Zhenjiang Pan1, Jing Bao1, Shepeng Wei1
1Department of Neurosurgery, Shidong Hospital, Shanghai, China.
Frontiers in oncology
|July 14, 2025
概括
沃拉西迪尼布是一种新的FDA批准的药物,用于IDH突变质瘤,显著改善无进展生存率. 这种向治疗可能会推迟低度质瘤患者的侵入性治疗.
科学领域:
- 神经瘤学神经瘤学
- 分子向疗法分子向疗法
- 临床试验分析临床试验分析
背景情况:
- IDH突变性质瘤是脑瘤的一个子集,具有特定的遗传变异.
- 目前针对低度结质瘤的治疗选择往往涉及侵入性手术,并可能产生显著的副作用.
- 需要有针对性的疗法,可以改善IDH突变质瘤患者的治疗结果和生活质量.
研究的目的:
- 在FDA批准后,审查双IDH1/2抑制剂vorasidenib的临床影响.
- 分析vorasidenib在治疗2级IDH突变天体细胞瘤和寡质细胞瘤中的疗效和安全性.
- 讨论vorasidenib在目前和不断变化的结质瘤治疗环境中的作用.
主要方法:
- 对关键INDIGO临床试验数据的审查.
- 对vorasidenib的药理动力学和安全性概况的分析.
- 探索治疗模式,包括警等待,向治疗和组合方法.
主要成果:
- 在INDIGO试验中,在接受vorasidenib治疗的患者中,无进展生存率显著改善.
- 沃拉西迪尼布表现出可管理的安全性概况和确定的剂量指南.
- 该药物显示有潜力延迟放射治疗和化疗的需要,保持生活质量.
结论:
- 沃拉西迪尼布在IDH突变质瘤的治疗中取得了重大进展,提供了向治疗的选择.
- 它的批准标志着神经瘤学向精准医学的转变.
- 多学科的护理和以患者为中心的决策对于将vorasidenib最佳地整合到质瘤治疗计划中至关重要.
相关概念视频
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
01:28Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K